Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1995
06/07/1995EP0656360A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
06/07/1995EP0656353A1 Aminochinoline derivates useful in the treatment of malaria
06/07/1995EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates
06/07/1995EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/07/1995EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
06/07/1995EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655920A1 Astragalus polysaccharide immunomodulators
06/07/1995EP0655919A1 Treatment of human viral infections
06/07/1995EP0454783B1 Site specific in-vivo activation of therapeutic drugs
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1103291A Preparation for skin and mucous membrane
06/06/1995US5422347 Fungicides, hair and skin disorders
06/06/1995US5422274 Internal deletion mutants of soluble T4(CD4)
06/06/1995US5422103 Wound healing agents for burns, bed sores; blended with dextran
06/06/1995US5422100 Method and product for treating skin afflictions
06/06/1995CA1335790C Influenza vaccine
06/04/1995CA2137186A1 Erythromycine derivatives, a process for their preparation and use as drugs
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014713A2 Abundant extracellular products and methods for their production and use
06/01/1995WO1995014707A1 N-2 substituted purines
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995WO1995014697A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995WO1995014684A1 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
06/01/1995WO1995014680A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995WO1995014670A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014667A1 Substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995WO1995014483A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex
06/01/1995WO1995014479A1 Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity
06/01/1995WO1995014475A1 The use of an ester of inositoltrisphosphate for the preparing of medicaments
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995WO1995014436A1 A retrograde high frequency tissue splitter
06/01/1995WO1995014385A1 Triazole phosphonate pesticides
06/01/1995WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon
06/01/1995WO1995005384A1 Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
06/01/1995CA2224051A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2224049A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2177375A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2177256A1 Triazole phosphonate pesticides
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2176961A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals
05/1995
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655072A1 Equine herpesvirus glycoproteins
05/31/1995EP0654999A1 Use of inhibitors of vacuolar-type h?+ atpases
05/31/1995EP0654968A1 Anti-microbial composition
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
05/31/1995EP0375724B1 Biologically active bactericidal/permeability-increasing protein fragments
05/31/1995CN1102979A Toothpaste containing medicine for anti-pylorus spirabacillus
05/30/1995US5420350 Germicides
05/30/1995US5420277 Intermediates for the preparation of heteroaryl derivatives of monocyclic beta-lactam antiobiotics
05/30/1995US5420272 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
05/30/1995US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof
05/30/1995US5420154 Administering a 2-pyrrolidinone derivative to an animal suffering from a tumor necrosis factor mediated disease
05/30/1995US5420140 Difluorinated quinolones useful for treating bacterial infections
05/30/1995US5420122 3-pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid compounds
05/30/1995US5420030 Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof
05/30/1995US5420019 Stable bactericidal/permeability-increasing protein muteins
05/30/1995US5419913 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
05/30/1995US5419908 Sanitizing composition comprising a blend of aromatic and polyunsaturated carboxylic acids
05/30/1995US5419900 Autoimmune disease
05/30/1995CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
05/26/1995WO1995014083A1 Vaccine against mumps containing a jeryl-lynn virus strain
05/26/1995WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995WO1995014016A1 Prodrugs of an inhibitor of hiv protease
05/26/1995WO1995014014A2 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014013A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014012A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1995014011A2 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995WO1994027584A3 Arylating medicaments
05/26/1995CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2176044A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2176043A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2176041A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2174649A1 Prodrugs of an inhibitor of hiv protease
05/26/1995CA2174124A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/24/1995EP0654086A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants
05/24/1995EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE
05/24/1995EP0654037A1 Antiretroviral enantiomeric nucleotide analogs
05/24/1995EP0654036A1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs.
05/24/1995EP0654031A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
05/24/1995EP0654024A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
05/24/1995EP0653939A1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
05/24/1995EP0381700B1 The use of a fructooligosaccharid in the manufacture of a bacteriostatic composition for inhibiting the growth of Salmonella and a process for inhibiting the growth of Salmonella in a food animal
05/23/1995US5418243 Anticholesterol agents
05/23/1995US5418152 Acidic polycyclic ether antibiotic
05/23/1995US5417971 Vaccines for Actinobacillus pleuropneumoniae
05/23/1995CA1335655C Vaccines and diagnostic assays for haemophilus influenzae
05/18/1995WO1995013370A1 Haemophilus transferrin receptor genes
05/18/1995WO1995013291A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013278A1 Urea derivatives
05/18/1995WO1995013267A1 Pyrimidine-thioalkyl and alkylether compounds
05/18/1995WO1995013094A1 Treatment of bacterially-induced inflammatory diseases
05/18/1995WO1995013090A1 Improved interferon polymer conjugates
1 ... 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 ... 1798